Hofseth BioCare ASA

Symbol: HBC.OL

OSL

2.09

NOK

Market price today

  • -7.7400

    P/E Ratio

  • 0.0000

    PEG Ratio

  • 825.72M

    MRK Cap

  • 0.00%

    DIV Yield

Hofseth BioCare ASA (HBC-OL) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.08%

Operating Profit Margin

-0.51%

Net Profit Margin

-0.55%

Return on Assets

-0.27%

Return on Equity

-1.16%

Return on Capital Employed

-0.71%

Company general description and statistics

Sector: Healthcare
Industry: Biotechnology
CEO:Mr. Jon Olav Odegard
Full-time employees:69
City:Ålesund
Address:Kipervikgata 13
IPO:2011-12-02
CIK:

Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.

General Outlook

When we look at how much money they make before expenses, they keep 0.076% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.507%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.552%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.273% return, is a testament to Hofseth BioCare ASA's adeptness in optimizing resource deployment. Hofseth BioCare ASA's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of -1.162%. Furthermore, the proficiency of Hofseth BioCare ASA in capital utilization is underscored by a remarkable -0.709% return on capital employed.

Stock Prices

Hofseth BioCare ASA's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.3, while its low point bottomed out at $2.23. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Hofseth BioCare ASA's stock market.

Liquidity Ratios

Analyzing HBC.OL liquidity ratios reveals its financial health of the firm. The current ratio of 52.01% gauges short-term asset coverage for liabilities. The quick ratio (15.38%) assesses immediate liquidity, while the cash ratio (9.48%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio52.01%
Quick Ratio15.38%
Cash Ratio9.48%

Profitability Ratios

HBC.OL profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -53.89% underscores its earnings before tax deductions. The effective tax rate stands at -3.24%, revealing its tax efficiency. The net income per EBT, 102.38%, and the EBT per EBIT, 106.34%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -50.68%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin-53.89%
Effective Tax Rate-3.24%
Net Income per EBT102.38%
EBT per EBIT106.34%
EBIT per Revenue-50.68%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.52, it details the span from stock purchase to revenue.

cards.indicatorcards.value
Days of Sales Outstanding15
Days of Inventory Outstanding169
Operating Cycle196.66
Days of Payables Outstanding113
Cash Conversion Cycle84
Receivables Turnover13.02
Payables Turnover3.24
Inventory Turnover2.16
Fixed Asset Turnover1.17
Asset Turnover0.50

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.03, and free cash flow per share, -0.09, depict cash generation on a per-share basis. The cash per share value, 0.06, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.05, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share-0.03
Free Cash Flow per Share-0.09
Cash per Share0.06
Operating Cash Flow Sales Ratio-0.05
Free Cash Flow to Operating Cash Flow Ratio3.33
Cash Flow Coverage Ratio-0.07
Short Term Coverage Ratio-0.26
Capital Expenditure Coverage Ratio-0.43
Dividend Paid and Capex Coverage Ratio-0.43

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 35.06%, highlights its total liabilities relative to assets. With a debt-equity ratio of 3.27, we discern the balance between debt and equity financing. The long-term debt to capitalization, 69.89%, and total debt to capitalization, 76.58%, ratios shed light on its capital structure. An interest coverage of -12.99 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio35.06%
Debt Equity Ratio3.27
Long Term Debt to Capitalization69.89%
Total Debt to Capitalization76.58%
Interest Coverage-12.99
Cash Flow to Debt Ratio-0.07
Company Equity Multiplier9.33

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 0.48, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.27, reflects the portion of profit attributed to each share. The book value per share, 0.11, represents the net asset value distributed per share, while the tangible book value per share, -0.04, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share0.48
Net Income Per Share-0.27
Book Value Per Share0.11
Tangible Book Value Per Share-0.04
Shareholders Equity Per Share0.11
Interest Debt Per Share0.37
Capex Per Share-0.06

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 58.42%, indicates top-line expansion, while the gross profit growth, -291.34%, reveals profitability trends. EBIT growth, 1.91%, and operating income growth, 1.91%, offer insights into operational profitability progression. The net income growth, 22.35%, showcases bottom-line expansion, and the EPS growth, 27.03%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth58.42%
Gross Profit Growth-291.34%
EBIT Growth1.91%
Operating Income Growth1.91%
Net Income Growth22.35%
EPS Growth27.03%
EPS Diluted Growth27.03%
Weighted Average Shares Growth5.43%
Weighted Average Shares Diluted Growth5.43%
Operating Cash Flow Growth61.76%
Free Cash Flow Growth34.96%
10-Year Revenue Growth per Share-44.24%
5-Year Revenue Growth per Share105.94%
3-Year Revenue Growth per Share132.69%
10-Year Operating CF Growth per Share96.20%
5-Year Operating CF Growth per Share60.44%
3-Year Operating CF Growth per Share76.33%
10-Year Net Income Growth per Share62.37%
5-Year Net Income Growth per Share17.50%
3-Year Net Income Growth per Share11.75%
10-Year Shareholders Equity Growth per Share-87.72%
5-Year Shareholders Equity Growth per Share-68.38%
3-Year Shareholders Equity Growth per Share-86.64%
Receivables Growth5.52%
Inventory Growth-29.16%
Asset Growth-5.09%
Book Value per Share Growth-73.32%
Debt Growth31.32%
R&D Expense Growth-19.24%
SGA Expenses Growth98.95%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 1,148,011,220, captures the company's total value, considering both debt and equity. Income quality, 0.16, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.12, gauges operational efficiency, while the research and development to revenue, 5.77%, highlights investment in innovation. The ratio of intangibles to total assets, 14.17%, indicates the value of non-physical assets, and capex to operating cash flow, 137.03%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value1,148,011,220
Income Quality0.16
Sales General and Administrative to Revenue0.12
Research and Development to Revenue5.77%
Intangibles to Total Assets14.17%
Capex to Operating Cash Flow137.03%
Capex to Revenue-12.40%
Capex to Depreciation-65.00%
Graham Number0.80
Return on Tangible Assets-31.86%
Graham Net Net-0.69
Working Capital-120,874,001
Tangible Asset Value-14,145,000
Net Current Asset Value-217,976,001
Invested Capital3
Average Receivables14,460,500
Average Payables100,456,500
Average Inventory99,533,500
Days Sales Outstanding28
Days Payables Outstanding82
Days of Inventory On Hand123
ROIC-68.99%
ROE-2.55%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 19.74, and the price to book ratio, 19.74, reflect the market's valuation relative to the company's book value. The price to sales ratio, 4.27, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -24.41, and price to operating cash flows, -81.26, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio19.74
Price to Book Ratio19.74
Price to Sales Ratio4.27
Price Cash Flow Ratio-81.26
Enterprise Value Multiple-11.75
Price Fair Value19.74
Price to Operating Cash Flow Ratio-81.26
Price to Free Cash Flows Ratio-24.41
Price to Tangible Book Ratio24.75
Enterprise Value to Sales6.02
Enterprise Value Over EBITDA-12.79
EV to Operating Cash Flow-66.46
Earnings Yield-10.31%
Free Cash Flow Yield-3.96%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Hofseth BioCare ASA (HBC.OL) on the OSL in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -7.740 in 2024.

What is the ticker symbol of Hofseth BioCare ASA stock?

The ticker symbol of Hofseth BioCare ASA stock is HBC.OL.

What is company IPO date?

IPO date of Hofseth BioCare ASA is 2011-12-02.

What is company current share price?

Current share price is 2.090 NOK.

What is stock market cap today?

The market cap of stock today is 825719290.000.

What is PEG ratio in 2024?

The current 0.000 is 0.000 in 2024.

What is the number of employees in 2024?

In 2024 the company has 69.